Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying Anti-cancer Effects and Exploring the Mechanism of an MPS1/TTK Inhibitor in Gastric Cancer. | Cancer Res Treat | 2025 | 39668392 | PubTator, text mining | PubMed |
| Identification of Associations with Dermatologic Diseases through a Focused GWAS of the UK Biobank. | JID Innov | 2025 | 39624183 | PubTator, text mining | PubMed |
| Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores. | Cancer Sci | 2025 | 39604214 | PubTator, text mining | PubMed |
| The Pittsburgh Study: A Tiered Model to Support Parents during Early Childhood. | J Pediatr | 2025 | 39536860 | PubTator, text mining | PubMed |
| Identification and Characterization of Key Genes Associated with Amelogenesis. | Eur J Dent | 2025 | 39299262 | PubTator, text mining | PubMed |
| Comprehensive Bioinformatics Analysis and Machine Learning of TTK as a Transhepatic Arterial Chemoembolization Resistance Target in Hepatocellular Carcinoma. | Mol Biotechnol | 2025 | 38954354 | PubTator, text mining | PubMed |
| Identification of potential biomarkers for pancreatic ductal adenocarcinoma: a bioinformatics analysis. | Comput Methods Biomech Biomed Engin | 2025 | 38773913 | PubTator, text mining | PubMed |
| Identification and Verification of Metabolism-related Immunotherapy Features and Prognosis in Lung Adenocarcinoma. | Curr Med Chem | 2025 | 38500277 | PubTator, text mining | PubMed |
| Identification and validation of a novel nine-gene prognostic signature of stem cell characteristic in hepatocellular carcinoma. | J Appl Genet | 2025 | 38441798 | PubTator, text mining | PubMed |
| Yeast with elevated chromosome numbers are addicted to high levels of Mps1. | bioRxiv | 2025 | 36712123 | PubTator, text mining | PubMed |
| Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis. | Malawi Med J | 2024 | 40191558 | PubTator, text mining | PubMed |
| Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets. | Front Mol Biosci | 2024 | 39935706 | PubTator, text mining | PubMed |
| Identification of key signaling pathways and novel computational drug target for oral cancer, metabolic disorders and periodontal disease. | J Genet Eng Biotechnol | 2024 | 39674633 | PubTator, text mining | PubMed |
| Integrated analysis of hub genes and intrinsically disordered regions in triple-negative breast cancer. | J Genet Eng Biotechnol | 2024 | 39674628 | PubTator, text mining | PubMed |
| Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer: A Plausible Alliance to Enhance Cell Death. | Cancers (Basel) | 2024 | 39594688 | PubTator, text mining | PubMed |
| TTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis. | J Cancer Res Clin Oncol | 2024 | 39589549 | PubTator, text mining | PubMed |
| Identification and Validation of Telomere-Related Gene Signature in Intervertebral Disc Degeneration. | Cureus | 2024 | 39553152 | PubTator, text mining | PubMed |
| Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases. | ACS Pharmacol Transl Sci | 2024 | 39539259 | PubTator, text mining | PubMed |
| Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis. | Medicine (Baltimore) | 2024 | 39470543 | PubTator, text mining | PubMed |
| Prediction of Threonine-Tyrosine Kinase Receptor-Ligand Unbinding Kinetics with Multiscale Milestoning and Metadynamics. | J Phys Chem Lett | 2024 | 39392497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=9